The North America buprenorphine and naloxone market is witnessing steady growth as healthcare systems strengthen approaches to opioid use disorder treatment and recovery. Increasing awareness of medication-assisted treatment, improved access to addiction care, and continued efforts to reduce opioid-related harm are contributing to regional demand. The expansion of treatment programs and greater...